Quick Answer
CervoMed Inc. reported Cash And Cash Equivalents At Carrying Value of $8.24 million for the year ending 2025.
- CervoMed Inc. showed a decrease of -8.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CervoMed Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), CervoMed Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 8,265.2%.
- Historical annual values: Fiscal year 2025: $8.24 million | Fiscal year 2024: $9.00 million | Fiscal year 2023: $7.79 million | Fiscal year 2022: $4.09 million | Fiscal year 2021: $37.31 million | Fiscal year 2020: $18.52 million | Fiscal year 2019: $14.18 million | Fiscal year 2018: $7.99 million | Fiscal year 2017: $8.90 million | Fiscal year 2016: $1.55 million | Fiscal year 2015: $2.00 million | Fiscal year 2014: $2.34 million | Fiscal year 2013: $255.0 thousand | Fiscal year 2012: $312.1 thousand | Fiscal year 2011: $98.4 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: